Physician profile
Judith Green
NPI 1285921478
$2,396.83
in general payments reported to CMS, 2019-2025
23 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $313 · 2021: $323 · 2022: $305 · 2023: $380 · 2024: $287 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $489.74 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $278.95 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Cranial Technologies, INC | $275.53 | 2020-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $236.41 | 2020-2023 | Vpriv |
| Corium, LLC | $165.72 | 2022-2025 | Azstarys |
| Sobi, INC | $151.72 | 2019-2022 | |
| Kaleo, INC. | $110.48 | 2019-2024 | Auvi-Q |
| Seqirus USA INC | $77.91 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi Pasteur INC. | $74.04 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $62.93 | 2019-2024 | |
| Baxter Healthcare | $54.31 | 2022 | |
| Genentech USA, INC. | $49.20 | 2019-2020 | |
| Tris Pharma INC | $46.64 | 2019-2020 | |
| Genzyme Corporation | $43.35 | 2021 | |
| Pfizer INC. | $43.31 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $41.87 | 2019 | |
| Phadia US INC. | $39.10 | 2023-2024 | Immunocap |
| Astrazeneca Pharmaceuticals Lp | $34.68 | 2024 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $29.96 | 2023 | |
| Alexion Pharmaceuticals, INC. | $27.81 | 2025 | Koselugo |
| Neos Therapeutics, Lp | $23.59 | 2019 | |
| Aytu Biopharma, INC. | $22.09 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.49 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.